Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)
China flag China · Delayed Price · Currency is CNY
23.04
-1.18 (-4.87%)
At close: Sep 4, 2026

SHA:688806 Statistics

Total Valuation

SHA:688806 has a market cap or net worth of CNY 10.61 billion. The enterprise value is 10.66 billion.

Market Cap10.61B
Enterprise Value 10.66B

Important Dates

The next estimated earnings date is Wednesday, November 25, 2026.

Earnings Date Nov 25, 2026
Ex-Dividend Date n/a

Share Statistics

SHA:688806 has 460.55 million shares outstanding. The number of shares has increased by 24.05% in one year.

Current Share Class 460.55M
Shares Outstanding 460.55M
Shares Change (YoY) +24.05%
Shares Change (QoQ) -0.29%
Owned by Insiders (%) 21.71%
Owned by Institutions (%) 31.43%
Float 209.07M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 90.75
PB Ratio 136.73
P/TBV Ratio 231.02
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 91.15
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.83, with a Debt / Equity ratio of 7.41.

Current Ratio 1.83
Quick Ratio 1.42
Debt / Equity 7.41
Debt / EBITDA n/a
Debt / FCF -1.13
Interest Coverage -24.73

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -80.16%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count843
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 49.65
Average Volume (20 Days) 7,128,186

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHA:688806 had revenue of CNY 116.93 million and -510.54 million in losses. Loss per share was -1.31.

Revenue116.93M
Gross Profit 69.02M
Operating Income -492.27M
Pretax Income -511.39M
Net Income -510.54M
EBITDA -465.71M
EBIT -492.27M
Loss Per Share -1.31
Full Income Statement

Balance Sheet

The company has 553.93 million in cash and 575.01 million in debt, with a net cash position of -21.08 million or -0.05 per share.

Cash & Cash Equivalents 553.93M
Total Debt 575.01M
Net Cash -21.08M
Net Cash Per Share -0.05
Equity (Book Value) 77.61M
Book Value Per Share 0.13
Working Capital 354.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -445.99 million and capital expenditures -63.22 million, giving a free cash flow of -509.21 million.

Operating Cash Flow -445.99M
Capital Expenditures -63.22M
Depreciation & Amortization 26.56M
Net Borrowing 265.69M
Free Cash Flow -509.21M
FCF Per Share -1.11
Full Cash Flow Statement

Margins

Gross Margin 59.03%
Operating Margin -421.01%
Pretax Margin -437.36%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SHA:688806 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -24.05%
Shareholder Yield -24.05%
Earnings Yield -4.81%
FCF Yield -4.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1